Clinical Trials on Chronic Obstructive

Total 40061 results

UPECLIN HC FM Botucatu Unesp
Faculdade de Medicina do ABC; IEP São Lucas - Instituto de Ensino e Pesquisa; Hemocentro São Lucas and other collaborators

Unknown

Cell Therapy in Advanced Chronic Obstructive Pulmonary Disease Patients

Chronic Obstructive Pulmonary Disease (COPD)

Brazil
University of Southern Denmark
The Ministry of Science, Technology and Innovation, Denmark; Region of Southern...

Unknown

Prognosis and Treatment of COPD in Primary Care-use of Biomarkers (PROTECCT-M)

Chronic Obstructive Pulmonary Disease (COPD)

Denmark
Zhujiang Hospital
Guangzhou Institute of Respiratory Disease

Completed

Effects of CPAP Level on Respiratory Mechanics and Central Drive in Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

China
Beijing Chao Yang Hospital

Unknown

Evaluation of Reactive Oxygen Metabolites in the Value of COPD

COPD(Chronic Obstructive Pulmonary Disease)

China
Novartis Pharmaceuticals

Completed

QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) (ILLUMINATE)

Chronic Obstructive Pulmonary Disease (COPD)

Spain, Germany, Estonia, Hungary, Belgium, Czech Republic, Norway, Korea, Republic of, Lithuania
Minneapolis Veterans Affairs Medical Center

Completed

Effect of Supplemental Vitamin D on Skeletal Muscle Function in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease (COPD)

United States
Novartis

Completed

Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

France, Germany, Belgium, Spain, Turkey, Italy, Canada, Australia
GlaxoSmithKline

Completed

A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease)

Pulmonary Disease, Chronic Obstructive | Chronic Obstructive Pulmonary Disease (COPD)

Germany
Novartis

Completed

Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States, Spain, Turkey, France, Netherlands, Germany
University of Milan
IRCCS Azienda Ospedaliero-Universitaria di Bologna; Valduce Hospital; Ente Ospedaliero... and other collaborators

Completed

Optimization of Ventilator Setting for Acute Exacerbations of Chronic Obstructive Pulmonary Disease (NIMV01AECB)

Acute Exacerbation of Chronic Obstructive Airways Disease

Italy, Switzerland
Centre Hospitalier Intercommunal Creteil

Recruiting

Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease (CoStemCells)

Chronic Obstructive Pulmonary Disease | Chronic Obstructive Lung Disease

France
Imperial College Healthcare NHS Trust
National Institute for Health Research, United Kingdom

Terminated

The Role of Ambulatory Oxygen in Improving the Effectiveness of Pulmonary Rehabilitation for COPD Patients

Chronic Obstructive Pulmonary Diseases

United Kingdom
Zuzana Zbožínková, M.Sc.

Unknown

Czech Multicentre Research Database of Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Airway Disease

Czechia
Virginia Commonwealth University
Fisher and Paykel Healthcare

Completed

The Effect of Humidification on Mucus Rheology

Chronic Obstructive Pulmonary Disease(COPD)

United States
Strados Labs, Inc.

Withdrawn

Utility of Remote Lung Auscultation in Transitions of Care After Pulmonary Exacerbations of COPD

Chronic Obstructive Pulmonary Disease (COPD)

United States
Pulmatrix Inc.

Completed

A Phase 1b Study of PUR1800 in Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Mylan Inc.
Theravance Biopharma

Completed

A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Mylan Inc.
Theravance Biopharma

Completed

Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Mylan Inc.
Theravance Biopharma

Completed

Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Chiesi Farmaceutici S.p.A.

Completed

Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) (TRIVERSYTI)

COPD (Chronic Obstructive Pulmonary Disease)

China, Korea, Republic of, Taiwan
Hannover Medical School
CAPNETZ Stiftung

Completed

Study to Demonstrate That Antibiotics Are Not Needed in Moderate Acute Exacerbations of COPD

Chronic Obstructive Pulmonary Disease (COPD)

Germany
University of Aarhus

Completed

Tele Health Monitoring Service for Patients With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease, COPD

Denmark
Barcelona Institute for Global Health
KU Leuven; University Medical Center Groningen; University of Athens; University... and other collaborators

Completed

Non-interventional Cross-over Study to Reduce Items of PROactive Tools Measuring Physical Activity in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Netherlands, Greece, Belgium, United Kingdom
Novartis Pharmaceuticals

Withdrawn

Efficacy of Indacaterol 150 µg Versus Formoterol

Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals

Withdrawn

Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active Control (INITIATE)

Chronic Obstructive Pulmonary Disease (COPD)
Memorial Hospital of Rhode Island
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Translating The GOLD COPD Guidelines Into Primary Care Practice (LungAge)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Norwegian University of Science and Technology

Completed

Patient Education in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Effect and Costs

Chronic Obstructive Pulmonary Disease (COPD)

Norway
Novartis Pharmaceuticals

Completed

Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients (INHALATOR)

Chronic Obstructive Pulmonary Disease (COPD)

Brazil
AstraZeneca
Mitsubishi Tanabe Pharma Corporation

Completed

Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)

Chronic Obstructive Pulmonary Disease (COPD)

Japan
West Park Healthcare Centre

Completed

Effectiveness and Feasibility of Delivering an Education Program to Patients With an Acute Exacerbation of COPD

Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation

Canada
University of Pennsylvania

Terminated

A Prospective, Cohort Study of Hyperpolarized 3He MRI in Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States
Chest Hospital, Ministry of Health and Welfare,...

Completed

Respiratory Rehabilitation Exercises in Older Adults With Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

Taiwan
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary Disease (GLOW7)

Chronic Obstructive Pulmonary Disease (COPD)

China, Philippines, Korea, Republic of, India
AstraZeneca

Completed

Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease (COPD)

Romania, Ukraine, Denmark, Netherlands, Canada
Novartis Pharmaceuticals

Completed

Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

Japan
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease (INTRUST1)

Chronic Obstructive Pulmonary Disease (COPD)

United States, Colombia, Argentina, Germany, Spain, Turkey, Guatemala, Mexico, Australia, Denmark, South Africa, Philippines
Novartis

Completed

A Crossover Study to Determine the Effect on Lung Function of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control

Chronic Obstructive Pulmonary Disease (COPD)

Spain, Germany, South Africa, Australia, Poland, New Zealand, Netherlands
University of Sao Paulo

Completed

Magnesium Loading in Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

Brazil
King's College Hospital NHS Trust
University of Brighton

Completed

The Effects of a Home Exercise Video Programme for Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Lithuanian University of Health Sciences

Recruiting

Respiratory and Cardiovascular Alterations in Patients With Chronic Obstructive Pulmonary Disease

Cardiovascular Diseases | Quality of Life | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease Severe

Lithuania
Convexity Scientific Inc
COPD Foundation

Completed

Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD (ASPIRE)

Chronic Obstructive Pulmonary Disease | COPD | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease Severe

United States
University College, London
University of Cambridge; National Institute for Health Research, United Kingdom and other collaborators

Unknown

Development of an Optimal Antibiotic Regime for Long-term Therapy in Stable Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD).

United Kingdom
Sygehus Lillebaelt
Danmarks Lungeforening; Chiesi Foundation; Overlæge Jørgen Werner Schous og hustru...

Active, not recruiting

Does Chronic Obstructive Lung Disease Influence the Cognitive Function

Chronic Obstructive Pulmonary Disease

Denmark
National Taipei University of Nursing and Health...

Terminated

Bubble PEP Training Among Patient With Chronic Obstructive Pulmonary Disease in Pulmonary Function Effects

Chronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With Exacerbation

Taiwan
Mylan Inc.
Theravance Biopharma

Completed

A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD

Chronic Obstructive Pulmonary Disease (COPD)

United States
University Hospital, Ghent
GlaxoSmithKline; University Ghent

Completed

Pharmaceutical Care for Chronic Obstructive Pulmonary Disease (COPD) Study. (PHARMACOP)

Chronic Obstructive Pulmonary Disease (COPD)

Belgium
Optimum Patient Care
Respiratory Effectiveness Group; Boehringer Ingelheim Pharmaceutical Company... and other collaborators

Unknown

Advancing the Patient Experience in Chronic Obstructive Pulmonary Disease (APEX COPD) (APEX COPD)

Chronic Obstructive Pulmonary Disease (13645005)

United States
Swedish Intensive Care Registry

Completed

Survival After Failed First-line Non-invasive Ventilation in Acute on Chronic Obstructive Pulmonary Disease

Critical Care | Chronic Obstructive Airways Disease Exacerbated

Sweden
Poitiers University Hospital

Completed

Interest of Branched Chain Amino Acids Associated With a Respiratory Rehabilitation Program in Patients Broncho Chronic Obstructive Pulmonary Disease (REHABAAR)

Broncho Chronic Obstructive Pulmonary Disease

France
AstraZeneca

Completed

A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy

Chronic Obstructive Pulmonary Disease COPD

United States, Netherlands, Argentina, South Africa, Chile, Peru

Clinical Trials on Chronic Obstructive

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations